Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Discontinuation due to neuropsychiatric adverse events with efavirenz- and dolutegravir-based antiretroviral therapy: a comparative real-life study.
Fernández-Bargiela N, Rotea-Salvo S, Margusino-Framiñán L, Balboa-Barreiro V, Martín-Herranz I, Castro-Iglesias Á, Mena-De-Cea Á, López-Calvo S, Vázquez-Rodríguez P, Míguez-Rey E, Cid-Silva P. Fernández-Bargiela N, et al. Among authors: rotea salvo s. Eur J Hosp Pharm. 2022 Jul;29(4):207-211. doi: 10.1136/ejhpharm-2020-002374. Epub 2020 Oct 13. Eur J Hosp Pharm. 2022. PMID: 33051194 Free PMC article.
Effectiveness and safety of sofosbuvir/velpatasvir ± ribavirin vs glecaprevir/pibrentasvir in genotype 3 hepatitis C virus infected patients.
Margusino-Framiñán L, Cid-Silva P, Rotea-Salvo S, Mena-de-Cea Á, Suárez-López F, Vázquez-Rodríguez P, Delgado-Blanco M, Sanclaudio-Luhia AI, Martín-Herranz I, Castro-Iglesias Á. Margusino-Framiñán L, et al. Among authors: rotea salvo s. Eur J Hosp Pharm. 2020 Mar;27(e1):e41-e47. doi: 10.1136/ejhpharm-2019-002060. Epub 2020 Feb 7. Eur J Hosp Pharm. 2020. PMID: 32296504 Free PMC article.
Treatment of high-risk bleeding with susoctocog alfa in a patient with acquired haemophilia A and a nosocomial severe acute respiratory syndrome coronavirus 2 infection.
Fernández-Oliveira C, Rotea-Salvo S, Fernández-Docampo M, González-Piñeiro S, Martín-Herranz I. Fernández-Oliveira C, et al. Among authors: rotea salvo s. Eur J Hosp Pharm. 2023 May;30(3):177-179. doi: 10.1136/ejhpharm-2021-002805. Epub 2021 May 19. Eur J Hosp Pharm. 2023. PMID: 34011555 Free PMC article.
Renal profile of patients treated with elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide fumarate and dolutegravir/abacavir/lamivudine: 120-week results from a real-world cohort.
Rotea-Salvo S, Martínez-Pradeda A, Fernández-Oliveira C, Giménez-Arufe V, Balboa-Barreiro V, Margusino-Framiñán L, Mena-De-Cea Á, Vázquez-Rodríguez P, Castro-Iglesias Á, López-Calvo S, Martín-Herranz I, Míguez-Rey E, Cid-Silva P. Rotea-Salvo S, et al. Eur J Hosp Pharm. 2023 Jul;30(4):221-226. doi: 10.1136/ejhpharm-2021-002896. Epub 2021 Oct 14. Eur J Hosp Pharm. 2023. PMID: 34649965 Free PMC article.
Lipid profile changes associated with antiretroviral therapies in a real-world cohort.
Rotea-Salvo S, Giménez-Arufe V, Martínez-Pradeda A, Fernández-Oliveira C, Mena-de-Cea Á, Margusino-Framiñán L, Martín-Herranz I, Cid-Silva P. Rotea-Salvo S, et al. Farm Hosp. 2023 Sep-Oct;47(5):210-217. doi: 10.1016/j.farma.2023.04.007. Epub 2023 Jun 20. Farm Hosp. 2023. PMID: 37349200 Free article. English, Spanish.
Lipid profile changes associated with antiretroviral therapies in a real-world cohort.
Rotea-Salvo S, Giménez-Arufe V, Martínez-Pradeda A, Fernández-Oliveira C, Mena-de-Cea Á, Margusino-Framiñán L, Martín-Herranz I, Cid-Silva P. Rotea-Salvo S, et al. Farm Hosp. 2023 Sep-Oct;47(5):T210-T217. doi: 10.1016/j.farma.2023.07.005. Epub 2023 Sep 5. Farm Hosp. 2023. PMID: 37673703 Free article. English, Spanish.